<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Breast Cancer - Okell Surgery Notes</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="07-bladder-carcinoma.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 13.3%;"></div>
                        </div>
                       <span class="progress-text">Topic 8 of 60</span>
                    </div>
                    <a href="09-burns.html" class="nav-button">
                        <span class="nav-text">Next: Burns</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">BREAST CANCER: DIAGNOSIS AND MANAGEMENT</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: introduction -->
                <section id="introduction" class="content-section">
                    <div class="content-card">
                        <h3>Introduction</h3>
                        <ul class="enhanced-list">
                            <li>It is the commonest cause of cancer death in women</li>
                            <li>It accounts for 6% of all female death</li>
                        </ul>

                        <h3>Diagnosis</h3>
                        <p>Diagnosis is by <strong>Triple Assessment</strong>:</p>
                        <ol class="enhanced-list">
                            <li><strong>Clinical Evaluation:</strong> Lump and regional nodes</li>
                            <li><strong>Imaging:</strong> Ultrasound (< 35 years old) or Mammography (> 35 years old)</li>
                            <li><strong>Cytology or Histology:</strong> FNA or Core Biopsy</li>
                        </ol>
                    </div>
                </section>
                <!-- END: introduction -->

                <!-- START: clinical-presentation -->
                <section id="clinical-presentation" class="content-section">
                    <h2 class="section-heading">Clinical Presentation</h2>
                    <div class="content-card">
                        <h3>History</h3>
                        <h4>Presenting complaints</h4>
                        <ul class="enhanced-list">
                            <li><strong>Painless breast lump:</strong> more than 70% of patients.</li>
                            <li><strong>Painful breast lumps:</strong> due to ischaemia/necrosis, inflammatory carcinoma, lymphedema, local invasion (nerves/muscles), or infection.</li>
                            <li>Mass rapid growth / Changes with menses.</li>
                            <li>Nipple discharge.</li>
                            <li>Ulceration, irritation, or eczematous skin change.</li>
                        </ul>

                        <h4>Advanced disease symptoms</h4>
                        <ul class="enhanced-list">
                            <li>Chronic cough (lung metastasis)</li>
                            <li>Weight loss, anorexia, generalized fatigue</li>
                            <li>Upper limb swelling (axillary lymph node involvement)</li>
                            <li>Back pain (metastasis to spine)</li>
                            <li>Yellowness of eyes (Jaundice)</li>
                        </ul>

                        <h4>Predisposing Factors (Risk Factors)</h4>
                        <ol class="enhanced-list">
                            <li>Breast cancer in the contra lateral breast</li>
                            <li>Benign breast disease with hyperplasia and atypia / multiple papillomas</li>
                            <li>Advancing age > 50 years (Most ca 35-45 years)</li>
                            <li>Family history of breast cancer, GIT or ovarian cancer</li>
                            <li>Nulliparity</li>
                            <li>Early menarche (< 13) and late menopause (> 50)</li>
                            <li>Age at first delivery (If > 30 years, risk is 2x that of < 20 years)</li>
                            <li>Oral contraceptives</li>
                            <li>Hormonal replacement therapy (HRT)</li>
                            <li>Whether breast fed and Length of breastfeeding</li>
                            <li>Irradiation to chest (therapeutic or occupational)</li>
                            <li>Obesity</li>
                            <li>Cigarette smoking and Alcohol consumption</li>
                            <li>Diet (Fatty diet)</li>
                        </ol>
                    </div>
                </section>
                <!-- END: clinical-presentation -->

                <!-- START: physical-examination -->
                <section id="physical-examination" class="content-section">
                    <h2 class="section-heading">Physical Examination</h2>
                    <div class="content-card">
                        <h3>Inspection</h3>
                        <ul class="enhanced-list">
                            <li>Symmetry of the breasts, sizes, and Level of the nipples.</li>
                            <li>Nature of the nipples (everted/inverted, discharges).</li>
                            <li>Skin changes: ulcers, hyperpigmentation, peau d'orange.</li>
                        </ul>
                        <aside class="callout warning">
                            <h4 class="callout-title">Signs suggestive of carcinoma</h4>
                            <p>Obvious size discrepancy, nipple inversion, skin dimpling, scaling, and edema (peau d'orange).</p>
                        </aside>

                        <h3>Palpation</h3>
                        <ul class="enhanced-list">
                            <li>Start from the normal side.</li>
                            <li>Examine all quadrants (lower outer, lower inner, upper inner, upper outer) and the axillary tail.</li>
                            <li>Describe masses: Site, size, shape, temperature, skin changes, tenderness, margins, mobility/attachments, consistency.</li>
                            <li>Squeeze nipple for discharge.</li>
                        </ul>

                        <h3>Lymph Nodes</h3>
                        <p>Examine axillary nodes (apical, lateral, posterior, anterior) and supraclavicular nodes.</p>

                        <h3>Differential Diagnosis</h3>
                        <ul class="enhanced-list">
                            <li>Giant fibroadenoma</li>
                            <li>Fibrosarcoma</li>
                            <li>Deep breast mycosis</li>
                            <li>Chronic breast abscess (e.g., TB)</li>
                            <li>Secondary malignancies (melanoma, lung)</li>
                            <li>Cystosarcoma phyllodes</li>
                        </ul>
                    </div>
                </section>
                <!-- END: physical-examination -->

                <!-- START: investigations -->
                <section id="investigations" class="content-section">
                    <h2 class="section-heading">Investigations</h2>
                    <div class="content-card">
                        <h3>Imaging</h3>
                        
                        <h4>Mammography</h4>
                        <p>Most useful for detection of early breast cancer. Sensitivity decreased in young patients with dense tissue. Suggestive findings: stellate shape, irregular/spiculated margins, pleomorphic calcifications.</p>
                        
                        <div class="table-container">
                            <table>
                                <caption>BI-RADS Classification</caption>
                                <tr><td>0</td><td>Incomplete examination (requires further imaging)</td></tr>
                                <tr><td>I</td><td>Normal (follow-up in 1 year)</td></tr>
                                <tr><td>II</td><td>Benign (follow-up in 1 year)</td></tr>
                                <tr><td>III</td><td>Likely to be benign (follow-up in 6 months)</td></tr>
                                <tr><td>IV</td><td>Suspicious (Consider biopsy)</td></tr>
                                <tr><td>V</td><td>Highly suspicious for malignancy (Biopsy recommended)</td></tr>
                            </table>
                        </div>

                        <h4>Ultrasound</h4>
                        <p>Useful in younger patients (< 35) or women with fibrocystic change. Distinguishes solid from cystic lesions.</p>

                        <h3>Diagnostic Procedures</h3>
                        <ul class="enhanced-list">
                            <li><strong>Fine-needle aspiration (FNA):</strong> First-line for palpable mass/cysts.</li>
                            <li><strong>True-cut (core) needle biopsy:</strong> Gives architectural information and invasiveness. Distinct advantage over FNA.</li>
                            <li><strong>Receptor Status:</strong> Estrogen (ER) and Progesterone (PR) receptors (for Tamoxifen benefit). Also BRCA 1/2.</li>
                        </ul>

                        <h3>Other Lab Investigations</h3>
                        <p>FHG, LFT, U/E/C, Tumour markers (CEA, CA 15-3, CA 27.29), Chest x-ray.</p>
                    </div>
                </section>
                <!-- END: investigations -->

                <!-- START: histology-staging -->
                <section id="histology-staging" class="content-section">
                    <h2 class="section-heading">Histology & Staging</h2>
                    <div class="content-card">
                        <h3>WHO Classification</h3>
                        <p><strong>A) Epithelial</strong></p>
                        <ul class="enhanced-list">
                            <li><strong>Non-invasive:</strong> Ductal carcinoma in situ (DCIS), Lobular carcinoma in situ (LCIS)</li>
                            <li><strong>Invasive:</strong> Ductal (85%), Lobular (1%), Mucinous (5%), Papillary (<5%), Medullary (<5%)</li>
                        </ul>

                        <h3>TNM Staging</h3>
                        <div class="table-container">
                            <table>
                                <tr><td><strong>T (Tumor)</strong></td><td>T1: ≤ 2cm<br>T2: > 2cm but ≤ 5cm<br>T3: > 5cm<br>T4: Extension to chest wall/skin</td></tr>
                                <tr><td><strong>N (Nodes)</strong></td><td>N0: None<br>N1: Mobile ipsilateral axillary<br>N2: Fixed ipsilateral axillary<br>N3: Ipsilateral supraclavicular/internal mammary</td></tr>
                                <tr><td><strong>M (Metastasis)</strong></td><td>M0: None<br>M1: Distant metastases</td></tr>
                            </table>
                        </div>

                        <h3>Manchester Staging System</h3>
                        <ul class="enhanced-list">
                            <li><strong>Stage I:</strong> Tumor confined to breast. Skin involvement < tumor size.</li>
                            <li><strong>Stage II:</strong> Confined to breast + Palpable mobile axillary nodes.</li>
                            <li><strong>Stage III:</strong> Extends beyond breast (skin fixation > tumor size, ulceration, fixity to fascia).</li>
                            <li><strong>Stage IV:</strong> Distant metastases.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: histology-staging -->

                <!-- START: management -->
                <section id="management" class="content-section">
                    <h2 class="section-heading">MANAGEMENT</h2>
                    <div class="content-card">
                        <h3>Supportive</h3>
                        <p>Hydration, Hematinics/transfusion, Analgesia, Nutritional build up, Antibiotics (if infected), Counselling.</p>

                        <h3>Specific Management: Surgery</h3>
                        
                        <h4>1. Breast Conserving Surgery (BCS)</h4>
                        <p>Includes wide local excision (lumpectomy), quadrantectomy, or segmentectomy.</p>
                        <p><strong>Indications:</strong> Small (< 5cm) single tumours in large breast, peripheral location, no local advancement.</p>
                        <p><strong>Contraindications:</strong> Multicentricity, widespread multifocal disease, central tumours involving nipple, poor differentiation.</p>

                        <h4>2. Mastectomy</h4>
                        <p><strong>Indications:</strong> Large tumours, central tumours, multifocal disease, local recurrence, palliative (toilet mastectomy), prophylaxis.</p>
                        <p><strong>Types:</strong></p>
                        <ul class="enhanced-list">
                            <li><strong>Total/Simple Mastectomy:</strong> Removal of breast parenchyma + nipple-areolar complex (no node dissection).</li>
                            <li><strong>Modified Radical Mastectomy (MRM):</strong> Removal of breast + axillary nodes (Level I & II).</li>
                            <li><strong>Patey MRM:</strong> Adds removal of Level III nodes + division of pectoralis minor.</li>
                            <li><strong>Radical (Halsted):</strong> Obsolete. Removed breast, all nodes, and pectoralis major/minor.</li>
                        </ul>

                        <h4>Axillary Surgery</h4>
                        <p><strong>Sentinel Node Biopsy:</strong> Identifies first drainage node (radioisotope/blue dye). Avoids morbidity of full clearance if negative.</p>
                        <p><strong>Axillary Clearance:</strong> Levels 1 (below pect. minor), 2 (behind), 3 (above/medial).</p>

                        <h3>Radiotherapy</h3>
                        <p>Used to clear breast bed of residual tumour (locoregional control).</p>
                        <p><strong>Indications:</strong> After BCS (mandatory), extensive local disease, heavy node positive disease, bony metastasis (pain control).</p>

                        <h3>Chemotherapy</h3>
                        <p>Primary systemic (neoadjuvant) or Adjuvant (post-op).</p>
                        <ul class="enhanced-list">
                            <li><strong>CMF Regimen:</strong> Cyclophosphamide, Methotrexate, 5-Fluorouracil. (6 cycles monthly).</li>
                            <li>Greatest benefit in pre-menopausal women.</li>
                        </ul>

                        <h3>Hormonal Therapy</h3>
                        <p>For ER/PR positive tumours.</p>
                        <ol class="enhanced-list">
                            <li><strong>Tamoxifen (SERM):</strong> 20mg OD for 5 years. Reduces contralateral cancer risk by 40%. Side effects: Endometrial Ca, Thromboembolism.</li>
                            <li><strong>Aromatase Inhibitors (Anastrazole):</strong> For post-menopausal women.</li>
                            <li><strong>LHRH Analogues (Goserelin):</strong> Ovarian suppression in pre-menopausal women.</li>
                            <li><strong>Trastuzumab (Herceptin):</strong> Monoclonal antibody for HER2 positive tumours.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: management -->

                <!-- START: special-types -->
                <section id="special-types" class="content-section">
                    <h2 class="section-heading">Special Conditions</h2>
                    <div class="content-card">
                        <h3>Inflammatory Breast Cancer</h3>
                        <p>Appearance of inflamed breasts (red, warm, dimpled/peau d'orange) due to infiltration of lymphatics. Aggressive. Treatment similar to Stage IIIB/IV (Chemo, Hormonal, Radiation, potentially Mastectomy if responsive).</p>

                        <h3>Paget's Disease of the Nipple</h3>
                        <p>Rare form beginning in milk ducts spreading to nipple/areola skin. Skin appears crusted, red, or oozing. Better prognosis if nipple changes are the only sign.</p>

                        <h3>Recurrence</h3>
                        <p><strong>Local recurrence after lumpectomy:</strong> Mastectomy.</p>
                        <p><strong>Recurrence after mastectomy:</strong> Surgery/Radiation + Systemic therapy.</p>
                    </div>
                </section>
                <!-- END: special-types -->

                <!-- START: prevention-prognosis -->
                <section id="prevention-prognosis" class="content-section">
                    <h2 class="section-heading">Prevention & Prognosis</h2>
                    <div class="content-card">
                        <h3>Prevention</h3>
                        <ul class="enhanced-list">
                            <li>Breast self-examination (monthly from age 18).</li>
                            <li>Annual mammography (> 40 years).</li>
                            <li>Tamoxifen for high-risk healthy women.</li>
                            <li>Lifestyle modification.</li>
                            <li>Prophylactic mastectomy (strong family history).</li>
                        </ul>

                        <h3>Prognostic Factors</h3>
                        <h4>Chronological</h4>
                        <ul class="enhanced-list">
                            <li><strong>Age:</strong> Younger women have poorer prognosis.</li>
                            <li><strong>Tumor size:</strong> Correlates directly with survival.</li>
                            <li><strong>Lymph node status:</strong> Single best prognostic factor.</li>
                            <li><strong>Metastases:</strong> Worsens survival.</li>
                        </ul>
                        <h4>Biological</h4>
                        <ul class="enhanced-list">
                            <li><strong>Histological type:</strong> Tubular, mucinous have better prognosis.</li>
                            <li><strong>Histological grade:</strong> Tubule formation, pleomorphism, mitotic frequency.</li>
                            <li><strong>Receptor status:</strong> ER+ better prognosis.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: prevention-prognosis -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="07-bladder-carcinoma.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 13.3%;"></div>
                        </div>
                       <span class="progress-text">Topic 8 of 60</span>
                    </div>
                    <a href="09-burns.html" class="nav-button">
                        <span class="nav-text">Next: Burns</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>